, page-4. ASX - By Stock. gov and there is lots of good information about the trial. Market . 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. Share Not unexpected. 1950. Update - Notification regarding unquoted securities - IXC. ASX - General. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. is there any news release, or SP increasing due to only the market showing interestCreated with Sketch. IXC could also be worth $14 on a successful trial and licensing deal (or takeover). , page-5. ASX - By Stock. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. Transparency is our policy. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. 1. All IMO IXC Price at posting: 37. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease. Market . ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. , page-196. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. Plans & Pricing. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. ASX - General. Market Cap $102. , page-5. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Login to your CommSec account to buy. Appendix 4E and Annual Report, page-3. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. ASX - Short Term Trading. Market . . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. . ASX - By Stock. Created with Sketch. ASX - Day TradingI bought some today at 44. ASX - General. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. British Columbia, Selkirk Mountains. 5¢ Sentiment: Buy Disclosure: Held. . ASX - By Stock. ASX - By Stock. . 91%) As of 03:35PM EST. Latest Posts. . 4KB OECCreated with Sketch. 91%) As of 03:35PM EST. Join the HotCopper ASX share market forum today for free. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. Latest Posts. Given the quality of the posters on the IXC thread I am confident others will do the same. . Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. ASX - By Stock. But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forumInvestor PresentationMRDMount Ridley Mines REE Project: Drilling confirms continuous high-grade mineralisation. Market . Get the edge as an investor: Subscribe to our daily newsletter for EXCLUSIVE insights into HotCopper!. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. Created with Sketch. Just a matter of time really. , page-3. Is it just me or has IXC gone very quiet. Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Charts. , page-188. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. About 90 percent of the U. no point selling now. Management ticking boxes while shareholders continue to have a golden opportunity to invest near all time lows in a company that has continually de-risked the fundamentals thesis. Discover historical prices for IXC. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Created with Sketch. , page-35. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. . . . DJPIN. So your thesis is right on a long time time frame. Appreciate your input Dr T. ASX - Short Term Trading. June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. . Expand. Created with Sketch. These are 2007 numbers. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. . Latest Posts. Forums. 30 Haven’t supported share price since then on market . ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportA new thread to put trading comments / reasoning / opinions in. Very tempted to buy them back today at 19c. **Close price adjusted for splits and dividend and/or capital gain distributions. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. 7KB AVG: 22/11/2023 1:08 PM : 2023 AVG AGM Addresses and Presentation 35 pages 3. Charts. LoginJoin Now. Last updated 10. Charts. Invex Receives Approval for Paediatric Plan from the EMA, page-2. Forums. Notice of Quarterly Investor Call. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Target our investor community with our suite of Hotcopper Advertising opportunities. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. . Forums. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. 1. , page-3. Created with Sketch. IXC Price at posting: 23. Just another way to saying that we've got Patient 1 out of 240. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Currency in USD 38. , page-3. ASX - By Stock. , page-32. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. Market . Join HotCopper today. As thread states post your questions here and let’s start compiling a list. Forums. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. ASX - General. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. ASX - General. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited)At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . Australia's largest stock trading and investment forum Australia's #1 stock forumMay 18 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX THERAPEUTICS SEEKS TRADING HALT PENDING RELEASE ON RESULTS OF ITS PHASE II TRIAL & UNDERTAKING A. ASX - By Stock. Created with Sketch. Grabbed my first ever parcel in IXC yesterdy at 80c. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 0 Great analysis. , page-2. ASX - By Stock. ASX - Day Trading. . 8,369 likes · 140 talking about this · 1,407 were here. . ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. " Seems a bit rough, anyone would think they are trying to minimise the number of SH who 'attend' the AGM. , page-4. Click for more information. 50%. 0. Share I've got no issues with it. Market . ASX - General. 59pm 09/11/2023 ? HotCopper has news, discussion, prices and market data on INCITEC PIVOT LIMITED. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-2. Also took placement stock @$1. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-4. ASX - By Stock. Therefore Id bet the same bet with the same info again. . Market . ASX - Day Trading. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Created with Sketch. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Liked by Jackie Cox-Ziegler, CPHR. 1. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. International Markets. Created with. But since the cash holding is double the market cap, there most likely more upside than down side. . Charts. Here come the vultures. ASX - Short Term Trading. Invex to Present at Virtual ASX Small and Mid-Cap ConferenceHealth & BiotechMay 24, 2020|Tim BorehamSHAREFrom the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a. . ASX - By Stock. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . Market . Posted without a title, my bad hahaI was going for something like Invex - How much is it worth, when Phase 2 results hit in March 2020?Got this from IXC by email today. ASX - Day Trading. . Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. ASX - By Stock. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. Just unfortunate to hit the black swan so badly here, both the. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. Hopefully they hit the miracle, at least I get something back from this if it goes balls up which in the bio world at the moment is highly likely. Market . Created with Sketch. The fact it recovered and closed about the 1. ASX - Day TradingCreated with Sketch. 0. Forums. . ASX - Short Term Trading. Market . Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. IXC Price at posting: 45. ASX - Short Term Trading. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. 6% $DLM 50. Forums. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. Issue of Tranche 1 Placement Shares and Appendix 2A. . Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Latest Posts. 64440. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. Contrast that to data from Wales in 2017 which suggests that. . IXC Valuation Report MST. . Charts. I'm topping up. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. Created with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. . $100-200k might be the minimum for the market to take notice. Invex Therapeutics' Chief Scientific Officer, Professor Alexandra Sinclair, met with NASA's medical team. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. Invex Therapeutics Lists on ASXNo worries mate :), page-15. IXC below Example of that is NEUInvestor Presentation, page-3. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. . Quarterly Activities/Appendix 4C Cash Flow Report. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. ASX - Day TradingHere's a very good opportunity for people in Sydney. ASX - Day Trading. ASX - Day Trading. P3 will be kicked off in early CY2021. A new thread to put trading comments / reasoning / opinions in. There can't be many left who have a positive association with this stock (apart from seed investors), so I don't think token $10-20k director purchases will change anything. Share "Online registration will open 30 minutes before the Meeting. Market . If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. ASX - By Stock. Created with Sketch. Created with Sketch. Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Created with Sketch. is there any news release, or SP increasing due to only the market showing interest, page-2. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. Last updated 10. Created with Sketch. 0. , page-6. 6% $DLM 50. 43 Sentiment: Buy Disclosure: Held. ASX - By Stock. Target our investor community with our suite of Hotcopper Advertising opportunities. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. The announcement was certainly a setback but we're not dead in. Created with Sketch. Learn how it impacts everything we do. Jellyroll, arkangel, CD, balkanbroker to name a few have laid out some pretty compelling thesis' on where IXC will be heading. ASX - By Stock. Created with Sketch. Notification of cessation of securities - IXC. Created with Sketch. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. 63%. Report to HotCopper and itll be the end of it, cheers. Created with Sketch. Invex Granted Key European Patent for Exenatide, page-2. Top Smart Score Stocks. , page-2. . 2. . 8M ! Add to my watchlist. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Created with Sketch. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. 20 to $7. . 0¢ Sentiment: Buy Disclosure: Held. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Update - Notification regarding unquoted securities - IXC. Commodities. Can't see how this doesn't push up soon, page-508. Slow and steady with IXC. Forums. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Created with Sketch. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. Forex. Proposed listing date: 4 JULY 2019#Created with Sketch. Created with Sketch. Created with Sketch. . ASX - By Stock. . ASX - Day TradingCreated with Sketch. Latest Posts. ASX - Day TradingApril 20 (Reuters) - Invex Therapeutics Ltd (IXC) : MINISTRY OF HEALTH APPROVAL FOR IIH EVOLVE CLINICAL TRIAL IN ISRAELInvestor Presentation, page-2. Market open. That is fair and as I mentioned in my initial post when buying, the business is worth the cash in ST. Notification of cessation of securities - IXC. Timeline Annotations of the IXC Chart Story Thus Far - IXC IPO'd in mid 2019 with Phase II data due Mid 2020, stock performs very well on IPO with tight T20 - The stock rose in anticipation for the Mid 2020 Phase II data read out in early 2020 - Before crashing alongside the Covid 19 Market Crash Hysteria in March 2020 AND all volume the last 18 months has led to a higher T20 ownership) meanwhile we have a mere 3 posts regarding an IXC job listing for a CMO that's description can be interpreted as hinting at a second indication. 79 -0. ASX - General. 0. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. Created with Sketch. Charts. ASX - By Stock. , page-4. 1950. Sentiment for Invex Therapeutics Ltd. . Join the HotCopper ASX share market forum today for free. Discover historical prices for IXC. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. pause in tradingHere we go! AU and UK sites activated for immediate recruitment. Results of MeetingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. I find this very intriguing and positive that in last few weeks about 1.